Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study

Louise Vølund Larsen(Odense University Hospital), Jes Sloth Mathiesen(University of Southern Denmark), Dhananjaya Saranath, Šárka Dvořáková(Institute of Endocrinology), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Frédéric Castinetti(Inserm), S. Pinson(Hôpital Edouard Herriot), Delphine Mirebeau‐Prunier(Centre National de la Recherche Scientifique), P. Pigny(Centre Hospitalier Universitaire de Lille), Anne Barlier(Inserm), Minoru Kihara, Caterina Mian(University of Padua), Damijan Bergant(Institute of Oncology Ljubljana), Kornelia Hasse-Lazar(The Maria Sklodowska-Curie National Research Institute of Oncology), Akihiro Sakurai(Sapporo Medical University), Charis Eng(Cleveland Clinic), Kiyomi Horiuchi(Maebashi Red Cross Hospital), Berna İmge Aydoğan(Güven Hospital), Christian Godballe(University of Southern Denmark), Simona Censi(University of Padua), Trisha Dwight(The University of Sydney), Ana O. Hoff(Shanghai Jiao Tong University), Françoise Borson‐Chazot(Hospices Civils de Lyon), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Tsuneo Imai(Aichi Medical University), Thera P. Links(University Medical Center Groningen), Luciana Audi Castroneves(Universidade de São Paulo), Attila Patócs(Semmelweis University), Nelson Wohllk(Hospital del Salvador), Hartmut P.H. Neumann(University of Freiburg), Véronique Barbu(Inserm), Mariola Pęczkowska(Institute of Cardiology), Shinya Uchino(Noguchi Thyroid Clinic and Hospital Foundation), Barbara Jarząb(The Maria Sklodowska-Curie National Research Institute of Oncology)
Endocrine Connections
May 6, 2020
Cited by 34


Related Papers